Atrial Fibrillation Trial, Recruiting NCT06989775 Sponsor: AtriCure, Inc. Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06989775
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already scheduled and medically approved for open-heart surgery that requires the use of a heart-lung bypass machine and opening of the sac surrounding the heart.
  • People who are 65 years of age or older and have a stroke risk score (called CHA2DS2-VASc) of 3 or higher (confirm with trial site).

Who may not be able to join:

  • People with a documented history of atrial fibrillation (an irregular heartbeat) or atrial flutter at any time before the planned surgery.
  • People who have previously had any surgery or procedure that involved opening or entering the sac surrounding the heart.
  • People whose planned surgery will be performed without the use of a heart-lung bypass machine (called "off-pump" surgery).
  • People who have previously had the left atrial appendage (a small pouch in the heart) blocked, removed, or closed off, either surgically or through a non-surgical procedure.
  • People who have a permanent pacemaker already in place.
  • People with a condition where abnormal proteins or other substances build up in the heart muscle, such as amyloidosis.
  • People whose planned surgery will be performed through an approach other than a standard chest-opening (sternotomy) incision.
  • People whose planned surgery is a heart transplant or the long-term implantation of a device to help the heart pump blood.
  • People who have abnormal heart rhythms originating in the lower chambers of the heart (ventricular arrhythmia).
  • People with an active infection of the inner lining of the heart (endocarditis).
  • People with the most severe level of heart failure symptoms (classified as NYHA Class IV), meaning significant symptoms even at rest.
  • People who require a mechanical heart-assist balloon pump or intravenous medications to support heart function before surgery.
  • People who have an active infection anywhere in the body at the time of surgery that requires antibiotic treatment.
  • People with a known allergy to Nitinol (a metal alloy) or sensitivity to nickel.
  • People with a known medical condition where life expectancy is less than one year.
  • People with other health conditions that, in the opinion of the trial investigator, would make completing the trial's required procedures or visits unsuitable for them.
  • People who are currently enrolled in another clinical trial involving an investigational device or drug that could interfere with this trial.
  • People with significant mental impairment or psychiatric conditions that may prevent them from fully understanding the nature and requirements of the trial.
  • People who are pregnant.
  • People with known severe symptomatic carotid artery disease (a serious narrowing of the main arteries in the neck).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1 (513) 755-4100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
AtriCure, Inc.
Registry
ClinicalTrials.gov
Start date
24 October 2025
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Primary Effectiveness Endpoint; Primary Safety Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov